Pembrolizumab Radiation Recall Dermatitis Case Report

A 2026 case report details a severe adverse reaction in a 65-year-old male patient with head and neck carcinoma. The report, authored by figshare admin karger, describes the clinical presentation, timeline, and management of pembrolizumab-associated radiation recall dermatitis. It is a single-case supplementary document of 114.5 KB.

Use Cases

• Analyze the temporal relationship between pembrolizumab administration and symptom onset described in the case narrative.
• Review the documented clinical presentation, including symptoms like epidermal detachment and Nikolsky sign, for differential diagnosis.
• Study the described treatment response to prednisolone for managing severe radiation recall dermatitis.

Strengths

• Detailed clinical timeline spanning from diagnosis to adverse event and follow-up.
• Includes specific diagnostic findings such as skin biopsy results consistent with drug hypersensitivity.

Limitations

• Extremely limited scope as a single-case report with no patient cohort for statistical analysis.
• Contains no structured data columns or tabular records for computational analysis.

Provenance

Source

figshare

Collection Method

Clinical case documentation and reporting.

Time Range

Covers the patient's treatment timeline, concluding with a 2026 publication date.

Freshness

Last updated in April 2026.